Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Cancer Medicine|March 11, 2020
Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paperSimona Soverini, Francesco Albano, Renato Bassan, et al.Leukemia Research|April 26, 2025
Clinical impact of tyrosine kinases related mutations in NPM1 mutated acute myeloid leukaemia: A report from the Northern Italy Leukaemia Group (NILG) multicentre randomized trial 02/06Gianluca Cavallaro, Silvia Salmoiraghi, Roberta Cavagna, et al.Blood Cancer Journal|January 4, 2023
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF studyNicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, et al.American Journal of Hematology|July 23, 2020
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemiaFrancesco Mannelli, Giacomo Gianfaldoni, Sara Bencini, et al.Genes|August 23, 2020
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular AlterationsSilvia Salmoiraghi, Roberta Cavagna, Marie Lorena Guinea Montalvo, et al.Annals of Hematology|May 12, 2011
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphomaSergio Cortelazzo, Tamara Intermesoli, Elena Oldani, et al.European Journal of Haematology|December 27, 2019
Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemiaNicola Gökbuget, Hervé Dombret, Sebastian Giebel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2023
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALLRobin Foà, Renato Bassan, Loredana Elia, et al.Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.The Lancet. Haematology|December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemiaIbrahim Aldoss, Gail J Roboz, Renato Bassan, et al.Pageof 8